Northland Capmk Comments on Astera Labs Q1 Earnings

Astera Labs, Inc. (NASDAQ:ALAB) – Northland Capmk issued their Q1 2026 earnings estimates for Astera Labs in a report issued on Tuesday, February 11th. Northland Capmk analyst G. Richard forecasts that the company will earn $0.09 per share for the quarter. Northland Capmk currently has a “Strong-Buy” rating on the stock. The consensus estimate for Astera Labs’ current full-year earnings is ($0.45) per share. Northland Capmk also issued estimates for Astera Labs’ Q2 2026 earnings at $0.13 EPS, Q3 2026 earnings at $0.17 EPS and Q4 2026 earnings at $0.22 EPS.

A number of other analysts have also weighed in on ALAB. Barclays upped their target price on shares of Astera Labs from $87.00 to $135.00 and gave the stock an “overweight” rating in a research note on Friday, January 17th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Craig Hallum upped their target price on shares of Astera Labs from $105.00 to $125.00 and gave the stock a “buy” rating in a research note on Tuesday. JPMorgan Chase & Co. upped their target price on shares of Astera Labs from $70.00 to $110.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Finally, Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 target price on the stock in a research note on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $115.33.

Astera Labs Price Performance

Shares of ALAB opened at $88.19 on Thursday. The company’s 50-day simple moving average is $121.35 and its 200-day simple moving average is $82.90. Astera Labs has a 1 year low of $36.22 and a 1 year high of $147.39.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Monday, February 10th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%.

Insider Activity

In other news, Director Stefan A. Dyckerhoff sold 197,297 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $90.51, for a total value of $17,857,351.47. Following the completion of the sale, the director now directly owns 6,148 shares of the company’s stock, valued at approximately $556,455.48. This represents a 96.98 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Philip Mazzara sold 2,513 shares of the stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $90.81, for a total value of $228,205.53. Following the completion of the sale, the general counsel now directly owns 248,745 shares of the company’s stock, valued at $22,588,533.45. The trade was a 1.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 846,452 shares of company stock valued at $86,427,256.

Institutional Investors Weigh In On Astera Labs

Several large investors have recently modified their holdings of the company. Whittier Trust Co. of Nevada Inc. acquired a new stake in shares of Astera Labs during the fourth quarter worth $25,000. Steward Partners Investment Advisory LLC lifted its holdings in shares of Astera Labs by 99.0% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company’s stock worth $26,000 after purchasing an additional 99 shares during the period. Kestra Investment Management LLC acquired a new stake in shares of Astera Labs during the fourth quarter worth $28,000. Geneos Wealth Management Inc. acquired a new stake in shares of Astera Labs during the fourth quarter worth $36,000. Finally, Global Retirement Partners LLC lifted its holdings in shares of Astera Labs by 3,155.6% during the fourth quarter. Global Retirement Partners LLC now owns 293 shares of the company’s stock worth $39,000 after purchasing an additional 284 shares during the period. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.